Redirecting to deep profile of Dr. Chetan Sobti at Nichepharm Lifesciences...
Click here to continue
Below are the verified contact details to help you connect directly:
Email: dr.*****@nic******.com
Mobile: 92578*****
Estimated Net Worth: ₹0 – ₹500+ Cr (approx. $0 – $60M)
- Dr. Chetan Sobti is a co-founder and currently the CEO of Nichepharm Lifesciences Pvt. Ltd., playing a pivotal role in the company's strategic direction and growth.
- He previously served as the CEO and Director at Nitin Lifesciences Limited from 2016, with earlier experience as co-founder since 1995.
- Dr. Sobti has held significant positions that showcase his leadership in the pharmaceutical industry, focusing on both management and operational aspects.
- Under his leadership, Nichepharm Lifesciences acquired the remaining 24% shares from their joint venture partner, Recipharm AB, restoring 100% ownership of the company.
- His educational background includes a medical degree from Jawaharlal Nehru Medical College, contributing to his expertise in the lifesciences sector.
- Dr. Sobti has built a professional network with over 500 connections on LinkedIn, indicating his engagement in the industry and collaborations.
- The Sobti family maintains a strong influence in management, with Dr. Sobti and Mr. Nitin Sobti holding key leadership roles to drive the company’s vision.
- Nichepharm Lifesciences has seen growth and innovation under Dr. Sobti’s guidance, responding to challenges in the competitive pharmaceutical landscape.
Current appointment
Company Name |
Role |
Date |
Company ID |
Nichepharm Lifesciences Private Limited |
Director |
16 Oct 2019 |
U24230HR2019PTC083085 |
Carewell Pharmapack International Private Limited |
Director |
24 Apr 2023 |
U26109HR2020PTC085456 |
Nitin Pharmaceuticals Private Limited |
Director |
01 Sep 2006 |
U74899DL1993PTC053310 |
,
Previous appointment
Company Name |
Role |
Incorporation Date |
Last Updated |
Company ID |
Nitin Lifesciences Limited |
CEO(KMP) |
03 Mar 2005 |
11 November 2022 |
U73100HP2005PLC028049 |